Heart transplantation: Challenges facing the field

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 5, 2014, Pages

  Tonsho, Makoto ^a   Michel, Sebastian ^a   Ahmed, Zain ^a   Alessandrini, Alessandro ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BORTEZOMIB; CORTICOSTEROID; EVEROLIMUS; HEPARIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANTIBODY MEDIATED REJECTION; ARTICLE; CLINICAL TRIAL (TOPIC); COCULTURE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; KIDNEY INDUCED CARDIAC ALLOGRAFT TOLERANCE; KIDNEY TRANSPLANTATION; LIVER CELL; LIVER SINUSOID; LIVER SINUSOIDAL ENDOTHELIAL CELL; LIVER TRANSPLANTATION; META ANALYSIS (TOPIC); NEPHRECTOMY; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PLASMAPHERESIS; REGULATORY T LYMPHOCYTE; STELLATE CELL; THYMECTOMY; ANIMAL; DISEASE MODEL; HEART MUSCLE; HISTOCOMPATIBILITY; IMMUNOLOGY; KIDNEY; LIVER; PHYSIOLOGY; PRIMATE; PROCEDURES; SWINE; TRANSPLANTATION TOLERANCE; TRENDS;

ALLOGRAFTS; ANIMALS; DISEASE MODELS, ANIMAL; HEART TRANSPLANTATION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIVER; LIVER TRANSPLANTATION; MYOCARDIUM; PRIMATES; SWINE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 84899725310     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015636     Document Type: Article

References (137)

1. Abe M, Wang Z, de CA, Thomson AW. 2005. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am J Transplant 5: 1808-1819.
2. Abraham WT, Smith SA. 2013. Devices in the management of advanced, chronic heart failure. Nat Rev Cardiol 10: 98-110.
3. Aliabadi A, Grommer M, Cochrane A, Salameh O, Zuckermann A. 2013. Induction therapy in heart transplantation: Where are we now? Transpl Int 26: 684-695.
4. Allan JS, Wain JC, Schwarze ML, Houser SL, Benjamin LC, Madsen JC, Sachs DH. 2002. Modeling chronic lung allograft rejection in miniature swine. Transplantation 73: 447-453.
5. Amarnath S, Mangus CW, Wang JC, Wei F, He A, Kapoor V, Foley JE, Massey PR, Felizardo TC, Riley JL, et al. 2011. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med 3: 111ra120.
6. Aziz T, Burgess M, Khafagy R, Wynn Hann A, Campbell C, Rahman A, Deiraniya A, Yonan N. 1999. Bicaval and standard techniques in orthotopic heart transplantation: Medium-term experience in cardiac performance and survival. J Thorac Cardiovasc Surg 118: 115-122.
7. Berry GJ, Angelini A, Burke MM, Bruneval P, Fishbein MC, Hammond E, MillerD, NeilD, ReveloMP, Rodriguez ER, et al. 2011. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011). J Heart Lung Transplant 30: 601-611.
8. Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. 2001. Murine renal allografts: Spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 167: 4821-4827.
9. Blanche C, Kamlot A, Blanche DA, Kearney B, Wong AV, Czer LS, Trento A. 2001. Combined heart-kidney transplantation with single-donor allografts. J Thorac Cardiovasc Surg 122: 495-500.
10. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. 2004. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114: 701-712.
11. Brandt M, HarringerW, Hirt SW, Walluscheck KP, Cremer J, Sievers HH, Haverich A. 1997. Influence of bicaval anastomoses on late occurrence of atrial arrhythmia after heart transplantation. Ann Thorac Surg 64: 70-72.
12. Brown K, Moxham V, Karegli J, Phillips R, Sacks SH, Wong W. 2007. Ultra-localization of Foxp3{thorn} T cells within renal allografts shows infiltration of tubules mimicking rejection. Am J Pathol 171: 1915-1922.
13. Bruschi G, Busnach G, Colombo T, Radaelli L, Pedrazzini G, Garatti A, SansaloneCV, Frigerio M, Vitali E. 2007. Longterm follow-up of simultaneous heart and kidney transplantation with single donor allografts: Report of nine cases. Ann Thorac Surg 84: 522-527.
14. Calne R, Davies H. 1994. Organ graft tolerance: The liver effect. Lancet 343: 67-68.
15. Calne RY, Sells RA, Pena JR. 1969. Induction of immunological tolerance by porcine liver allografts. Nature 223: 472-476.
16. Cecka JM, Terasaki PI. 2003. Clinical transplants 2002. University of California, Los Angeles.
17. Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, et al. 2011a. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 53: 1007-1019.
18. Chou HS, Hsieh CC, Charles R, Wang L, Wagner T, Fung JJ, Qian S, Lu LL. 2011b. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of Tregulatory cells. Transplantation 93: 272-282.
19. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI, et al. 2012. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 31: 1073-1086.
20. Col VJ, Jacquet L, Squifflet JP, Goenen M, Noirhomme P, Goffin E, Pirson Y. 1998. Combined heart-kidney transplantation: Report on six cases. Nephrol Dial Transplant 13: 723-727.
21. Colucci V, Quaini E, Magnani P, Colombo T, De Carlis L, Grassi M, Merli M, Pellegrini A. 1997. Combined heart and kidney transplantation: An effective therapeutic option-Report of six cases. Eur J Cardiothorac Surg 12: 654-658.
22. Colvin-Adams M, Smith JM, Heubner BM, Skeans MA, Edwards LB, Waller C, Snyder JJ, Israni AK, Kasiske BL. 2013. OPTN/SRTR 2011 Annual Data Report: Heart. Am J Transplant 13: 119-148.
23. Cook CH, Bickerstaff AA, Wang JJ, Nadasdy T, Della Pelle P, Colvin RB, Orosz CG. 2008. Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J Immunol 180: 3103-3112.
24. Czer LS, Ruzza A, Vespignani R, Jordan S, De Robertis MA, Mirocha J, Gallagher SP, Patel K, Schwarz ER, Kass RM, et al. 2011. Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone. Transplant Proc 43: 3869-3876.
25. Dahmen U, Qian S, Rao AS, Demetris AJ, Fu F, Sun H, Gao L, Fung JJ, Starzl TE. 1994. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 58: 1-8.
26. Deckers JGM, Boonstr JG, Van der Kooij SW, Daha MR, van derWoude FJ. 1997. Tissue-specific characteristics of cytotoxic graft-infiltrating T cells during renal allograft rejection. Transplantation 64: 178-181.
27. Diehl L, Schurich A, Grochtmann R, Hegenbarth S, Chen L, Knolle PA. 2008. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8{thorn} T cell tolerance. Hepatology 47: 296-305.
28. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sørensen K, Hummel M, Lind JM, et al. 2003. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349: 847-858.
29. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206: 3015-3029.
30. Frasca L, Marelli-Berg F, Imami N, Potolicchio I, Carmichael P, Lombardi G, Lechler R. 1998. Interferon-g-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 53: 679-689.
31. Freimark D, Silverman JM, Aleksic I, Crues JV, Blanche C, Trento A, Admon D, Queral CA, Harasty DA, Czer LS. 1995. Atrial emptying with orthotopic heart transplantation using bicaval and pulmonary venous anastomoses: A magnetic resonance imaging study. J Am Coll Cardiol 25: 932-936.
32. Gehrie E, Van der TouwW, Bromberg JS, Ochando JC. 2011. Plasmacytoid dendritic cells in tolerance. Methods Mol Biol 677: 127-147.
33. Ghodsizad A, Bordel V, Ungerer M, Karck M, Bekeredjian R, Ruhparwar A. 2012. Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum 15: E161-E163.
34. Giangrande I, Yamada K, Arn S, Lorf T, Sachs DH, LeGuern C. 1997. Selective increase in CD4-positive graft-infiltrating mononuclear cells among the infiltrates in class I disparate kidney grafts undergoing rejection. Transplantation 63: 722-728.
35. Gill J, Shah T, Hristea I, Chavalitdhamrong D, Anastasi B, Takemoto SK, Bunnapradist S. 2009. Outcomes of simultaneous heart-kidney transplant in the US: A retrospective analysis using OPTN/UNOS data. Am J Transplant 9: 844-852.
36. Goldfarb DA. 2003. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: The liver does it, and the heart does it too. J Urol 169: 2435-2436.
37. Gonwa TA, Husberg BS, Klintmalm GB, Mai ML, Goldstein RM, Capehart JE, Miller AH, Johnston SB, Alivizatos PA. 1992. Simultaneous heart and kidney transplantation: A report of three cases and review of the literature. J Heart Lung Transplant 11: 152-155.
38. Griesemer AD, LaMattina JC, Okumi M, Etter JD, Shimizu A, Sachs DH, Yamada K. 2008. Linked suppression across an MHC-mismatched barrier in a miniature swine kidney transplantation model. J Immunol 181: 4027-4036.
39. Groetzner J, Kaczmarek I, Mueller M, Huber S, Deutsch A, Daebritz S, Arbogast H, Meiser B, Reichart B. 2005. Freedom from graft vessel disease in heart and combined heart-and kidney-transplanted patients treated with tacrolimus-based immunosuppression. J Heart Lung Transplant 24: 1787-1792.
40. Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I. 2013. Tenyear results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. Transplantation 95: 629-634.
41. Hadley GA, Rostapshova EA, Bartlett ST. 1996. Dominance of tissue-restricted cytotoxic T lymphocytes in the response to allogeneic renal epithelial cell lines. Transplantation 62: 75-83.
42. Hagerty DT, Allen PM. 1992. Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 148: 2324-2330.
43. Hart AJ, Smellie WA, Calne RY. 1971. Fate of kidney allografts from cadavers whose livers were also transplanted. Lancet 1: 103-105.
44. Hermsen JL, Nath DS, del Rio AM, Eickstaedt JB, Wigfield C, Lindsey JD, Edwards NM. 2007. Combined heart-kidney transplantation: The University of Wisconsin experience. J Heart Lung Transplant 26: 1119-1126.
45. Hershberger RE, Starling RC, Eisen HJ, Bergh CH, Kormos RL, Love RB, Van Bakel A, Gordon RD, Popat R, Cockey L, et al. 2005. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 352: 2705-2713.
46. Hunt SA, Haddad F. 2008. The changing face of heart transplantation. J Am Coll Cardiol 52: 587-598.
47. Ierino FL, Yamada K, Hatch T, Rembert J, Sachs DH. 1999. Peripheral tolerance to class I mismatched renal allografts in miniature swine: Donor antigen-activated peripheral blood lymphocytes from tolerant swine inhibit antidonor CTL reactivity. J Immunol 162: 550-559.
48. Jacob S, Sellke F. 2009. Is bicaval orthotopic heart transplantation superior to the biatrial technique? Interact Cardiovasc Thorac Surg 9: 333-342.
49. Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH. 1995. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59: 256-262.
50. Kawai T, Poncelet A, Sachs DH, Mauiyyedi S, Boskovic S, Wee SL, Ko DS, Bartholomew A, Kimikawa M, Hong HZ, et al. 1999. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68: 1767-1775.
51. Kawai T, Cosimi AB, Wee SL, Houser S, Andrews D, Sogawa H, Phelan J, Boskovic S, Nadazdin O, Abrahamian G, et al. 2002. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 73: 1757-1764.
52. Kawai T, Sogawa H, Boskovic S, Abrahamian G, Smith RN, Wee SL, Andrews D, Nadazdin O, Koyama I, Sykes M, et al. 2004. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 4: 1391-1398.
53. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, et al. 2008. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358: 353-361.
54. Kelishadi SS, Azimzadeh AM, Zhang T, Stoddard T, Welty E, Avon C, Higuchi M, Laaris A, Cheng XF, McMahon C, et al. 2010. Preemptive CD20{thorn} B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest 120: 1275-1284.
55. Kim JM, Rasmussen JP, Rudensky AY. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197.
56. Kirby JA, Rajasekar MR, Lin Y, Proud G, Taylor RM. 1993. Interaction between T lymphocytes and kidney epithelial cells during renal allograft rejection. Kidney Int Suppl 39: S124-S128.
57. Kittleson MM, Kobashigawa JA. 2012. Antibody-mediated rejection. Curr Opin Organ Transplant 17: 551-557.
58. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. 1995. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 22: 226-229.
59. Kobashigawa JA. 2012. The future of heart transplantation. Am J Transplant 12: 2875-2891.
60. Kobashigawa JA, Miller LW, Russell SD, Ewald GA, Zucker MJ, Goldberg LR, Eisen HJ, Salm K, Tolzman D, Gao J, et al. 2006. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-Year report. AmJ Transplant 6: 1377-1386.
61. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, et al. 2011. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 30: 252-269.
62. Kocher AA, Schlechta B, Kopp CW, Ehrlich M, Ankersmit J, Ofner P, Langer F, Berlakovich GA, Grimm M, Wolner E, et al. 1998. Combined heart and kidney transplantation using a single donor: A single center's experience with nine cases. Transplantation 66: 1760-1763.
63. Krupnick AS, Gelman AE, BarchetW, Richardson S, Kreisel FH, Turka LA, Colonna M, Patterson GA, KreiselD. 2005. Murine vascular endothelium activates and induces the generation of allogeneic CD4{thorn}25{thorn}Foxp3{thorn} regulatory T cells. J Immunol 175: 6265-6270.
64. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, PrabharasuthDD, Cheng J, Moran K, et al. 2005. Heart transplantation in baboons using a-1, 3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 11: 29-31.
65. Leeser DB, Jeevanandam V, Furukawa S, Eisen H, Mather P, Silva P, Guy S, Forster CE III. 2001. Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant 1: 89-92.
66. Leyh RG, Jahnke AW, Kraatz EG, Sievers HH. 1995. Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation. Ann Thorac Surg 59: 1495-1500.
67. Li W, Kuhr CS, Zheng XX, Carper K, Thomson AW, Reyes JD, Perkins JD. 2008. New insights into mechanisms of spontaneous liver transplant tolerance: The role of Foxp3-expressing CD25{thorn}CD4{thorn} regulatory T cells. Am J Transplant 8: 1639-1651.
68. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, Momburg F, Arnold B, Knolle PA. 2000. Efficient presentation of exogenous antigen by liver endothelial cells to CD8{thorn} T cells results in antigen-specific T-cell tolerance. Nat Med 6: 1348-1354.
69. Liu SM, Lee DH, Sullivan JM, Chung D, Jäger A, Shum BO, Sarvetnick NE, Anderson AC, Kuchroo VK. 2011. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD. Idd3 mice. J Clin Invest 121: 4303-4310.
70. Lower RR, Shumway NE. 1960. Studies on orthotopic homotransplantation of the canine heart. Surg Forum 11: 18-19.
71. Luckraz H, Parameshwar J, Charman SC, Firth J, Wallwork J, Large S. 2003. Short-and long-term outcomes of combined cardiac and renal transplantation with allografts from a single donor. J Heart Lung Transplant 22: 1318-1322.
72. Madariaga ML, Michel SG, Tasaki M, Villani V, LaMuraglia GM II, Sihag S, Gottschall J, Farkash EA, Shimizu A, Allan JS, et al. 2013. Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation. Am J Transplant doi: 10. 1111/ajt. 12423.
73. Madsen JC. 1998. Cardiac allograft vasculopathy in miniature swine: Utility of a large animal model. Graft 1: 41-44.
74. Madsen JC, Sachs DH, Fallon JT, Weissman NJ. 1996. Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanisms. J Thorac Cardiovasc Surg 111: 1230-1239.
75. Madsen JC, Morris PJ, Wood KJ. 1997. Immunogenetics of heart transplantation in rodents. Transplant Rev 11: 141-150.
76. Madsen JC, Yamada K, Allan JS, Choo JK, Erhorn AE, Pins MR, Vesga L, Slisz JK, Sachs DH. 1998. Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-Disparate miniature swine. Transplantation 65: 304-313.
77. Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. 2003. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108: 48-53.
78. Massicot-Fisher J, Noel P, Madsen JC. 2001. Recommendations of the NHLBI heart and lung tolerance working group. Transplantation 72: 1467-1470.
79. Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW. 2005. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5: 314-322.
80. Mezrich JD, Kesselheim JA, Johnston DR, Yamada K, Sachs DH, Madsen JC. 2003a. The role of regulatory cells in miniature swine rendered tolerant to cardiac allografts by donor kidney cotransplantation. Am J Transplant 3: 1107-1115.
81. Mezrich JD, Yamada K, Lee RS, Mawulawde K, Benjamin LC, Schwarze ML, Maloney ME, Amoah HC, Houser SL, Sachs DH, et al. 2003b. Induction of tolerance to heart transplants by simultaneous cotransplantation of donor kidneys may depend on a radiation-sensitive renal-cell population. Transplantation 76: 625-631.
82. Mezrich J, Yamada K, Sachs DH, Madsen JC. 2004. Regulatory T cells generated by the kidney may mediate the beneficial immune effects of combining kidney with heart transplantation. Surgery 135: 473-478.
83. Mezrich JD, Benjamin LC, Sachs JA, Houser SL, Vagefi PA, Sachs DH, Madsen JC, Yamada K. 2005. Role of the thymus and kidney graft in the maintenance of tolerance to heart grafts in miniature swine. Transplantation 79: 1663-1673.
84. Miyajima M, Chase CM, Alessandrini A, Farkash EA, Della Pelle P, Benichou G, Graham JA, Madsen JC, Russell PS, Colvin RB. 2011. Early acceptance of renal allografts in mice is dependent on Foxp3{thorn} cells. Am J Pathol 178: 1635-1645.
85. Mohib K, Guan Q, Diao H, Du C, Jevnikar AM. 2007. Proapoptotic activity of indoleamine 2, 3-dioxygenase expressed in renal tubular epithelial cells. AmJ Physiol Renal Physiol 293: F801-F812.
86. Nair N, Ball T, Uber PA, Mehra MR. 2011. Current and future challenges in therapy for antibody-mediated rejection. J Heart Lung Transplant 30: 612-617.
87. Narula J, Bennett LE, DiSalvo TG, Hosenpud JD, Semigran MJ, Dec GW. 1997. Outcomes in recipients of combined heart-kidney transplantation. Multi-organ, same-donor transplant study of the ISHLT/UNOS scientific registry. Transplantation 63: 861-867.
88. Norman JC, Brook MI, Cooley DA, Klima T, Kahan BD, Frazier OH, Keats AS, Hacker J, Massin EK, Duncan JM, et al. 1978. Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1: 1125-1127.
89. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, Angeli V, Li Y, Boros P, Ding Y, et al. 2006. Alloantigenpresenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7: 652-662.
90. Okumi M, Scalea JR, Gillon BC, Tasaki M, Villani V, Cormack T, Hirakata A, Shimizu A, Sachs DH, Yamada K. 2013. The induction of tolerance of renal allografts by adoptive transfer in miniature swine. Am J Transplant 13: 1193-1202.
91. Opelz G, Margreiter R, Dohler B. 2002. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: The liver does it, and the heart does it too. Transplantation 74: 1390-1394.
92. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. 2008. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221.
93. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, Servillo G, Brunacci C, Calvitti M, Bicciato S, et al. 2011. Indoleamine 2, 3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12: 870-878.
94. Patel J, Everly M, Chang D, Kittleson M, Reed E, Kobashigawa J. 2011. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation. J Heart Lung Transplant 30: 1320-1326.
95. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP. 2004. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 172: 1009-1017.
96. Praseedom RK, McNeilKD, Watson CJ, Alexander GJ, Calne RY, Wallwork J, Friend PF. 2001. Combined transplantation of the heart, lung, and liver. Lancet 358: 812-813.
97. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. 1994. Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 19: 916-924.
98. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, et al. 2009. Combined heart and liver transplantation: A single-center experience. Transplantation 88: 219-225.
99. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. 1995. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59: 919-921.
100. Robertson H, Wong WK, BurtAD, Mohamed MA, TalbotD, Kirby JA. 2001. Relationship between TGF-b1, intratubular CD103 positive T cells and acute renal allograft rejection. Transplant Proc 33: 1159.
101. Rosengard BR, Ojikutu CA, Guzzetta PC, Smith CV, Sundt TMIII, Nakajima K, Boorstein SM, Hill GS, Fishbein JM, Sachs DH. 1992. Induction of specific tolerance to class I disparate renal allografts in miniature swine with cyclosporine. Transplantation 54: 490-497.
102. Russell PS, Chase CM, Colvin RB, Plate JM. 1978. Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med 147: 1449-1468.
103. Sachs DH. 1992. MHC homozygous miniature swine. In Swine as models in biomedical research (ed. Swindle MM, et al.), pp. 3-15. Iowa State University Press, Ames, IA.
104. Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wuthrich RP. 2004. Suppressed T-cell activation by IFN-g-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant 19: 2713-2720.
105. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, et al. 2012. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489: 322-325.
106. Singer GG, Yokoyama H, Bloom RD, Jevnikar AM, Nabavi N, Kelley VR. 1993. Stimulated renal tubular epithelial cells induce anergy in CD4{thorn} T cells. Kidney Int 44: 1030-1035.
107. Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ. 2006. CX3CR1{thorn} interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70: 591-596.
108. Sriwatanawongsa V, Davies HS, Calne RY. 1995. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1: 428-432.
109. Stehlik J, Islam N, Hurst D, Kfoury AG, Movsesian MA, Fuller A, Delgado JC, Hammond ME, Gilbert EM, Renlund DG, et al. 2009. Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant 28: 1129-1134.
110. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI, et al. 2012. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 31: 1052-1064.
111. Sumpter TL, Abe M, Tokita D, Thomson AW. 2007. Dendritic cells, the liver, and transplantation. Hepatology 46: 2021-2031.
112. Te HS, Anderson AS, Millis JM, JeevanandamV, Jensen DM. 2008. Current state of combined heart-liver transplan-tation in the United States. J Heart Lung Transplant 27: 753-759.
113. Tiegs G, Lohse AW. 2010. Immune tolerance: What is unique about the liver. J Autoimmun 34: 1-6.
114. Tonsho M, Benichou G, Boskovic S, Nadazdin O, Smith N, Colvin R, Sachs D, Cosimi A, Kawai T, Madsen J. 2013. Successful tolerance induction of cardiac allografts in nonhuman primates through donor kidney co-transplantation. 2013 American Transplant Congress, Seattle, WA, May 18-22.
115. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, et al. 2013. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation 95: 859-865.
116. Trachiotis GD, Vega JD, Johnston TS, Berg A, Whelchel J, Smith AL, Lutz J, Kanter KR. 2003. Ten-year follow-up in patients with combined heart and kidney transplantation. J Thorac Cardiovasc Surg 126: 2065-2071.
117. Traversi E, Pozzoli M, Grande A, Forni G, Assandri J, Viganò M, Tavazzi L. 1998. The bicaval anastomosis technique for orthotopic heart transplantation yields better atrial function than the standard technique: An echocardiographic automatic boundary detection study. J Heart Lung Transplant 17: 1065-1074.
118. Utsugi R, Barth RN, Lee RS, Kitamura H, LaMattina JC, Ambroz J, Sachs DH, Yamada K. 2001. Induction of transplantation tolerance with a short course of tacrolimus (FK506). I: Rapid and stable tolerance to two-haplotype fully MHC-mismatched kidney allografts in miniature swine. Transplantation 71: 1368-1379.
119. Valantine H. 2007. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. J Heart Lung Transplant 26: 557-564.
120. Vermes E, Kirsch M, Houël R, Legouvelo S, Benvenuti C, Aptecar E, Le Besnerais P, Lang P, Abbou C, Loisance D. 2001. Immunologic events and long-term survival after combined heart and kidney transplantation: A 12-year single-center experience. J Heart Lung Transplant 20: 1084-1091.
121. Vermes E, Grimbert P, Sebbag L, Barrou B, Pouteil-Noble C, Pavie A, Obadia JF, Loisance D, Lang P, Kirsch M. 2009. Long-term results of combined heart and kidney transplantation: A French multicenter study. J Heart Lung Transplant 28: 440-445.
122. Veronese F, Rotman S, Smith RN, Pelle TD, Farrell ML, Kawai T, Benedict Cosimi A, Colvin RB. 2007. Pathological and clinical correlates of FOXP3{thorn} cells in renal allografts during acute rejection. AmJ Transplant 7: 914-922.
123. von Oppen N, Schurich A, Hegenbarth S, Stabenow D, Tolba R, Weiskirchen R, Geerts A, Kolanus W, Knolle P, Diehl L. 2009. Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology 49: 1664-1672.
124. Walsh RC, Alloway RR, Girnita AL, Woodle ES. 2012. Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int 81: 1067-1074.
125. Wang SS, Chou NK, Chi NH, Hsu RB, Huang SC, Chen YS, Yu HY, Ko WJ, Chu SH, Tsai MK, et al. 2006. Simultaneous heart and kidney transplantation for combined cardiac and renal failure. Transplant Proc 38: 2135-2137.
126. Wang C, Cordoba S, Hu M, Bertolino P, Bowen DG, Sharland AF, Allen RD, Alexander SI, McCaughan GW, Bishop GA. 2011. Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transpl Immunol 24: 149-156.
127. Wood KJ, Sakaguchi S. 2003. Regulatory T cells in transplantation tolerance. Nat Rev 3: 199-210.
128. Wu A, Yamada K, Ierino FL, Vagefi PA, Sachs DH. 2003. Regulatory mechanism of peripheral tolerance: In vitro evidence for dominant suppression of host responses during the maintenance phase of tolerance to renal allografts in miniature swine. Transpl Immunol 11: 367-374.
129. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK. 2008. Retinoic acid increases Foxp3{thorn} regulatory T cells and inhibits development of Th17 cells by enhancing TGF-b-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181: 2277-2284.
130. Yamada K, Choo JK, Allan JS, Erhorn AE, Menard MT, Mawulawde K, Slisz JK, Aretz HT, Shimizu A, Sachs DH, et al. 1999. The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model. Transplantation 68: 485-491.
131. Yamada K, Mawulawde K, Menard MT, Shimizu A, Aretz HT, Choo JK, Allison KS, Slisz JK, Sachs DH, Madsen JC. 2000. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: The effect of augmentation of donor antigen load. J Thorac Cardiovasc Surg 119: 709-719.
132. Yamada Y, Boskovic S, Aoyama A, Murakami T, Putheti P, Smith RN, Ochiai T, Nadazdin O, Koyama I, Boenisch O, et al. 2012. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant 12: 330-340.
133. Yang HR, Chou HS, Gu X, Wang L, Brown KE, Fung JJ, Lu L, Qian S. 2009. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon-g signaling. Hepatology 50: 1981-1991.
134. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ, Lu L, Qian S. 2004. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40: 1312-1321.
135. Zhang Z, Zhu L, Quan D, Garcia B, Ozcay N, Duff J, Stiller C, Lazarovits A, Grant D, Zhong R. 1996. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62: 1267-1272.
136. Zheng SG. 2008. The critical role of TGF-b1 in the development of induced Foxp3{thorn} regulatory T cells. Int J Clin Exp Med 1: 192-202.
137. Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S. 2012. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant 12: 2487-2497.